NHS to offer precision prostate cancer treatment, cutting radiotherapy doses required
NHS England is set to offer thousands of men with prostate cancer a form of targeted radiation therapy for the…
All articles by Ross Law
Ross Law
Ross Henry Law is a reporter for Medical Device Network. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer's disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.
-
-
GT Medical Technologies raises $100m for brain tumour therapy advance
GT Medical Technologies has raised $100m to advance its radiation therapy implant for treating brain tumours. The Arizona-based company’s oversubscribed…
-
Novanta outlays $1.45bn for Riverpoint Medical buyout
Novanta has agreed to acquire Riverpoint Medical for an upfront price of $1.2bn to expand its portfolio into the minimally…
-
FDA clears Xenix Medical’s Lux fusion system
Xenix Medical has obtained US Food and Drug Administration (FDA) clearance for its Lux expandable lumber interbody fusion system and…
-
FDA issues early alert for GE HealthCare’s infant resuscitation systems
The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ device issue with certain GE…
-
ADA26: Dexcom’s G7 CGM helps TD2 diabetics not on insulin manage glucose levels
New data from Dexcom has demonstrated the benefit of its G7 continuous glucose monitor (CGM) in type 2 diabetes (TD2)…
-
Zepto Life Technology’s mould infection panel obtains FDA breakthrough designation
Zepto Life Technology’s invasive mould detection test has secured a breakthrough device designation from the US Food and Drug Administration…
-
Sophia Genetics and MSK join forces to develop precision oncology hub
SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center (MSK) have signed a memorandum of understanding (MoU) that will set in…
-
CereVasc raises $85m to advance hydrocephalus treatment
CereVasc has raised $85m, providing the clinical stage company with a cash runway to support the ongoing development of its…
-
ResMed completes $340m Noctrix Health acquisition
Noctrix Health has been acquired by ResMed in a $340m deal, representing the first portfolio company exit for Angelini Ventures,…